Urgent

Neurosarcoidosis

CNS sarcoidosis · Neurology
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Granulomatous inflammation of the nervous system occurring in a minority of patients with sarcoidosis, presenting variably with cranial neuropathy (classically facial palsy), meningitis, myelopathy or hypothalamic-pituitary dysfunction. Diagnosis is challenging and treatment is immunosuppressive.

Red flags

  • Rapid neurological deterioration or cord compression
  • Hydrocephalus from basal meningitis
  • Hypothalamic-pituitary failure (adrenal crisis, diabetes insipidus)
  • Undiagnosed TB mimicking sarcoid
  • Visual loss from optic neuropathy

Assessment

Differential diagnosis

  • Multiple sclerosis and other demyelination
  • Tuberculous or other chronic meningitis
  • CNS lymphoma
  • Vasculitis
  • Behcet's disease
  • Idiopathic cranial neuropathy

Investigations

  • MRI brain and spine with contrast (leptomeningeal enhancement, parenchymal lesions)
  • CSF analysis (lymphocytic pleocytosis, raised protein, oligoclonal bands, raised ACE)
  • Serum ACE and calcium (insensitive)
  • CT chest / PET to find systemic disease and a biopsy target
  • Tissue biopsy (extra-neural if possible) showing non-caseating granulomas
  • Exclude TB and infection before immunosuppression

Management

  • Suspect neurosarcoidosis in subacute cranial neuropathy, aseptic meningitis or myelopathy
  • Seek systemic sarcoidosis (chest imaging, PET) to obtain accessible biopsy confirmation
  • Perform MRI with contrast and CSF analysis
  • Rigorously exclude infection, especially TB, before immunosuppression
  • Start corticosteroids as first-line therapy for active disease
  • Add a steroid-sparing immunosuppressant for relapsing or steroid-dependent disease
  • Use TNF-alpha inhibitors (infliximab) for refractory disease
  • Monitor and manage endocrine dysfunction from hypothalamic-pituitary involvement
  • Treat seizures and other symptomatic complications
  • Taper steroids slowly with specialist follow-up

Drugs & doses

Prednisolone 0.5-1 mg/kg PO daily, tapering over months
Methylprednisolone 1 g IV daily for 3-5 days for severe presentations
Methotrexate 10-25 mg PO/SC weekly (steroid-sparing)
Azathioprine or mycophenolate as alternatives
Infliximab 5 mg/kg IV infusion for refractory disease

Disposition

Specialist neurology with respiratory/sarcoidosis multidisciplinary input. Admission for severe presentations. Long-term immunosuppression monitoring.

Complications & pitfalls

  • Permanent neurological deficit
  • Hydrocephalus
  • Hypopituitarism and endocrine failure
  • Immunosuppression-related infection
  • Relapse on steroid withdrawal

Exam pearls

  • Facial nerve palsy is the classic cranial neuropathy in neurosarcoidosis
  • Always exclude TB before immunosuppressing granulomatous CNS disease
  • Biopsy of accessible systemic disease avoids risky neural biopsy
  • Serum ACE is neither sensitive nor specific; do not rely on it

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.